¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31
±³À°ÀÏÀÚ : 2024-05-31
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø ¿¬±¸°ü

±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸

´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í ºñȸ¿ø 50,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 13:30~14:00 Clinical significance of BRAFV600E-positive cells as measurable residual disease (MRD) in Langerhans cell histiocytosi Ko Kudo(Hirosaki University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 14:00~14:30 How we treat LCH(Langerhans cell histiocytosis) in Taiwan Grace Yu Mei Liao(Medical University, Taiwan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 14:30~15:00 Unraveling the Genetic Tapestry of Langerhans Cell Histiocytosis in Korean Patients °í°æ³²(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 15:15~15:45 Stratified treatment of pediatric HLH(Hemophagocytic lymphohistiocytosis) Rui Zhang(Capital  Medical University, China)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 15:45~16:15 Primary and secondary hemophagocytic lymphohistiocytosis in Japan Shouichi Ohga(Kyushu University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 16:15~16:45 HLH(Hemophagocytic lymphohistiocytosis) in Korea ÃÖÁ¤À±(¼­¿ïÀÇ´ë )

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 17:00~17:30 CAR-T related CSS & cytopenia Yoshiyuki Takahashi(Nagoya University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 17:30~18:00 CAR-T related HLH(Hemophagocytic lymphohistiocytosis) À¯Àç¿ø(°¡Å縯ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀ忬±¸ÇÐȸ ºÎ¿ï°æÁöȸ Á¤±âÁý´ãȸ : 2024-04-29
´ÙÀ½±Û ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
900 ¼­¿ï ÇѾç´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-10-27 0 632 2018-09-12
899 °­¿ø °­¸ª¾Æ»êº´¿ø ¾Ï Áø´Ü°ú Ä¡·áÀÇ ÃÖ½ÅÁö°ß 2018 update : 2018-10-27 0 1,106 2018-09-12
898 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ´ëÇÑôÃß¿Ü°úÇÐȸ 2018 Àü°øÀÇ Ã߰迬¼ö°­Á : 2018-10-27 0 787 2018-09-12
897 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ECHO 360 : 2018-10-27 0 1,197 2018-09-12
896 ´ë±¸ ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2018 Ãß°èÇмú´ëȸ DAY 2 : 2018-10-27 0 366 2018-09-12
895 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ½ÉÈ­±³À°(»çÀüµî·Ï Çʼö) : 2018-10-26 0 412 2018-09-12
894 °æ±â ´Ü±¹´ëÇб³º´¿ø ¾È¼º½Ã ÀÇ»çȸ ¿¬¼ö°­Á : 2018-10-26 0 644 2018-09-12
893 ¼­¿ï 2018 ÀÓ»ó½ÃÇè±Û·Î¹ú¼±µµ¼¾ÅÍ ½ÉÆ÷Áö¾ö (Global Trends in Clinical Trials and Translational Research) : 2018-10-26 0 437 2018-09-12
892 ´ë±¸ ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2018 Ãß°èÇмú´ëȸ DAY 1 : 2018-10-26 0 425 2018-09-12
891 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ½ÉÈ­±³À°(»çÀüµî·Ï Çʼö) : 2018-10-24 0 626 2018-09-12
890 °æ³² °æ»ó³²µµÀÇ»çȸ ³²ºÎ°æ³² ¿¬¼ö±³À° : 2018-10-24 0 1,274 2018-09-12
889 ¼­¿ï ´ëÇѽŻý¾ÆÇÐȸ Á¦1ȸ KNN ½ÉÆ÷Áö¾ö : 2018-10-20 0 909 2018-09-12
888 ¼­¿ï 2018³â À»Áö´ëÇб³ À»Áöº´¿ø È£Èí±â¾Ë·¹¸£±â³»°ú ¿¬¼ö°­Á : 2018-10-20 0 875 2018-09-12
887 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø The 26th Asan Ventilator Workshop : 2018-10-20 0 1,365 2018-09-12
886 ¼­¿ï 2018³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãß°è ½ÉÆ÷Áö¾ö : 2018-10-19 0 444 2018-09-12
1341 | 1342 | 1343 | 1344 | 1345 | 1346 | 1347 | 1348 | 1349 | 1350
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷